Podoplanin suppresses the cell adhesion of epidermal keratinocytes via functional regulation of β1-integrin
Epidermal stem cells adhere more efficiently to the extracellular matrix (ECM) than the less adhesive differentiating cells due to their high expression of cell adhesion molecules including β1-integrin. Podoplanin is majorly expressed in the markedly proliferative and differentiating basal cells of the wounded and psoriatic epidermis. This study was designed to reveal podoplanin’s function in human epidermal keratinocytes (HEK) focusing on its interaction with β1-integrin. We analyzed the adhesion and differentiation of HEK in both podoplanin-overexpressing and -knock-down cells, considering their β1-integrin levels. The basal layer of IL-22-treated hyperproliferative reconstituted epidermis cells (simulating basal hyperproliferative psoriatic epidermal basal cells) expressed higher podoplanin levels than the untreated control cells. The adhesiveness of HaCaT cells, which do not express podoplanin, was reduced after the overexpression of podoplanin. HEK with podoplanin overexpression suppressed the cell adhesion to type I collagen (while downregulating β1-integrin functions) and podoplanin silencing augmented it (by increasing active ECM-bound β1-integrin). The increased cell adhesion to type I collagen induced by podoplanin silencing could be reversed by addition of P5D2, a neutralizing antibody against β1-integrin. In the psoriatic epidermis, podoplanin expression was especially upregulated on the rete ridges of the basal cell layer. This expression pattern was inversely correlated with the total/ECM-bound active β1-integrin-expression, which was stronger at the basal cell layer covering the dermal papillae. Our results indicate that podoplanin inhibits the cell ECM attachment by suppressing β1-integrin and initiating HEK differentiation. Podoplanin is presumably involved in the pathogenesis of psoriasis.
KeywordsPsoriasis Epidermis Differentiation Stem cell Therapeutic target
This study was supported in part by a Grant 15K08582 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This study was conducted according to the Declaration of Helsinki and the study protocol was approved by the Asahikawa Medical University ethical committee.
- 1.Allen TD, Potten CS (1974) Fine-structural identification and organization of the epidermal proliferative unit. J Cell Sci 15:291–319Google Scholar
- 2.Billick E, Mitsui H, Gulati N, Fujita H, Gilleaudeau P, Sullivan-Whalen M, Johnson-Huang LM, Suárez-Fariñas M, Krueger JG (2012) Human keratinocytes’ response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J Investig Dermatol 132:105–113. https://doi.org/10.1038/jid.2011.262 CrossRefGoogle Scholar
- 4.Charruyer A, Fong S, Vitcov G, Sklar S, Tabernik L, Taneja M, Caputo M, Soeung C, Yue L, Uchida Y, Arron S, Horton K, Foster R, Sano S, North J, Ghadially R (2017) Brief report: interleukin-17A-dependent asymmetric stem cell divisions are increased in human psoriasis: a mechanism underlying benign hyperproliferation. Stem Cells 35:2001–2007CrossRefGoogle Scholar
- 7.Fujii M, Honma M, Takahashi H, Ishida-Yamamoto A, Iizuka H (2012) Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility. Cell Signal 25:760–765. https://doi.org/10.1016/j.cellsig.2012.12.004 CrossRefGoogle Scholar
- 8.Haslett PA, Phipps KM, Krueger JG, Fretzin S, Cameron GS, Mccolm J, Katcherian A, Cueto I, White T (2012) IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 130:145–154. https://doi.org/10.1016/j.jaci.2012.04.024 CrossRefGoogle Scholar
- 11.Honma M, Minami-Hori M, Takahashi H, Iizuka H (2012) Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22. J Dermatol Sci 65:134–140. https://doi.org/10.1016/j.jdermsci.2011.11.011 CrossRefGoogle Scholar
- 15.Kinouchi M, Takahashi H, Itoh Y, Ishida-Yamamoto A, Iizuka H (2002) Ultraviolet B irradiation increases keratin 5 and keratin 14 expression through epidermal growth factor receptor of SV40-transformed human keratinocytes. Arch Dermatol Res 293:634–641. https://doi.org/10.1007/s00403-001-0284-9 CrossRefGoogle Scholar
- 24.Ochoa-Alvarez JA, Krishnan H, Shen Y, Acharya NK, Han M, McNulty DE, Hasegawa H, Hyodo T, Senga T, Geng J-G, Kosciuk M, Shin SS, Goydos JS, Temiakov D, Nagele RG, Goldberg GS (2012) Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration. PLoS One 7:e41845. https://doi.org/10.1371/journal.pone.0041845 CrossRefGoogle Scholar
- 25.Papp KA, Reich K, Paul C, Blauvelt A, Baran W, Bolduc C, Toth D, Langley RG, Cather J, Gottlieb AB, Thac D (2016) A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. Br J Dermatol 175:273–286. https://doi.org/10.1111/bjd.14493 CrossRefGoogle Scholar
- 29.Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G, Detmar M (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 22:3546–3556. https://doi.org/10.1093/emboj/cdg342 CrossRefGoogle Scholar